This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jung, C. Articles by Jeng, M.-H. Search for Related Content PubMed PubMed Citation Articles by Jung, C. Articles by Jeng, M.-H.

HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling

Departments of ¹ Urology, ² Medicine, and ³ Microbiology and Immunology, Walther Oncology Center, Indiana University, Indianapolis, Indiana

Androgen receptor (AR) signals play a decisive role in regulating the growth and differentiation of both normal and cancerous prostate cells by triggering the regulation of target genes, in a process in which AR cofactors have critical functions. Because of the highly prostate-specific expression pattern of HOXB13, we studied the role of this homeodomain protein in prostate cells. Expression of HOXB13 was limited to AR-expressing prostate cells. Reporter transcription assay demonstrated that HOXB13 significantly suppressed hormone-mediated AR activity in a dose-responsive manner, and suppression was specific to AR with which HOXB13 physically interacts. Overexpression of HOXB13 further down-regulated the androgen-stimulated expression of prostate-specific antigen, and suppression of endogenous HOXB13 stimulated transactivation of AR. Functionally, HOXB13 suppressed growth of LNCaP prostate cancer cells, which could be counteracted by additional hormone-activated AR. On the other hand, the growth-suppressive function of HOXB13 in AR-negative CV-1 cells was not affected by AR. These results suggest that HOXB13 functions as an AR repressor to modulate the complex AR signaling and subsequent growth regulation of prostate cancer cells. In addition to the loss of HOXB13 expression, maintaining AR may be an important step for prostate cancer cells to tolerate the suppressor function of HOXB13. Altogether, our data present a novel mechanism for the HOXB13-mediated repression of AR signaling, which can be interpreted to a growth-suppressive event.

This article has been cited by other articles:

				X. Wu, Y. Gong, J. Yue, B. Qiang, J. Yuan, and X. Peng Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing Nucleic Acids Res., June 1, 2008; 36(11): 3590 - 3599. [Abstract] [Full Text] [PDF]

				H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF]

				J. Miao, Z. Wang, H. Provencher, B. Muir, S. Dahiya, E. Carney, C.-O. Leong, D. C. Sgroi, and S. Orsulic HOXB13 promotes ovarian cancer progression PNAS, October 23, 2007; 104(43): 17093 - 17098. [Abstract] [Full Text] [PDF]

				L. Huang, Y. Pu, D. Hepps, D. Danielpour, and G. S. Prins Posterior Hox Gene Expression and Differential Androgen Regulation in the Developing and Adult Rat Prostate Lobes Endocrinology, March 1, 2007; 148(3): 1235 - 1245. [Abstract] [Full Text] [PDF]

				M. P.H.M. Jansen, A. M. Sieuwerts, M. P. Look, K. Ritstier, M. E. Meijer-van Gelder, I. L. van Staveren, J. G.M. Klijn, J. A. Foekens, and E. M.J.J. Berns HOXB13-to-IL17BR Expression Ratio Is Related With Tumor Aggressiveness and Response to Tamoxifen of Recurrent Breast Cancer: A Retrospective Study J. Clin. Oncol., February 20, 2007; 25(6): 662 - 668. [Abstract] [Full Text] [PDF]

				C. J Burd, L. M Morey, and K. E Knudsen Androgen receptor corepressors and prostate cancer Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994. [Abstract] [Full Text] [PDF]

				H. Lei, A. H. Juan, M.-S. Kim, and F. H. Ruddle Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells PNAS, July 5, 2006; 103(27): 10305 - 10309. [Abstract] [Full Text] [PDF]

				J. A. Mack, L. Li, N. Sato, V. C. Hascall, and E. V. Maytin Hoxb13 Up-regulates Transglutaminase Activity and Drives Terminal Differentiation in an Epidermal Organotypic Model J. Biol. Chem., August 19, 2005; 280(33): 29904 - 29911. [Abstract] [Full Text] [PDF]